Rob Steller, OD
Vision Therapy Optometrist in Jeffersonville, Indiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 376 in Vision Therapy Optometrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Rob Steller, OD reported a CMS MIPS final score of 78.4/100 - below the 83.5 national average - and filed 247 Medicare Part D claims in 2024.
- 78.4/100
- MIPS score · -5 vs avg
- 247
- Part D claims, 2024
- 66%
- generic prescribing
- $148.75
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Rob Steller, OD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1982796066), first enumerated 09/28/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 247 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 78.4/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$148.75 in reported industry payments (4 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1982796066 · Vision Therapy Optometrist
NPI-10 · ENUM-LEGACY · TAX-TRACE · MIPS-BELOW · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1982796066
- ENUM-LEGACY 2006
- TAX-TRACE 376
- MIPS-BELOW 78.4/100
- RX-LIGHT 247
- BOOK-THIN 9 in Indiana
- PHOTO-FINISH Joshua Black, OD · ±1.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Joshua Black, OD…
Joshua Black, OD
77.4 MIPS pts
- Steller · this p…
Steller · this provider
78.4 MIPS pts
- Adam Peiffer, O.…
Adam Peiffer, O.D.
79.5 MIPS pts
- Myoung Hee Han, …
Myoung Hee Han, O.D.
79.7 MIPS pts
- Rima Bakhru, O.D…
Rima Bakhru, O.D
79.7 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Rob Steller, OD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
78 ≥ 23rd percentile 23% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Rob Steller, OD sits
This provider among vision therapy optometrist peers
Across the 19 vision therapy optometrist providers who report both Medicare Part D prescribing and a MIPS quality score, Rob Steller, OD writes more Part D claims than 53% of them and scores higher on MIPS quality than 37% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one vision therapy optometrist peer from a representative sample of 18; the gold marker is Rob Steller, OD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Rob Steller, OD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Indiana
How Vision Therapy Optometrist compares to other specialties among Indiana providers
Vision Therapy Optometrist ranks #312 among Indiana's specialties (0% of in-state providers)
Each bar is a specialty's share of the Indiana provider total, by primary NUCC taxonomy. The highlighted bar is Vision Therapy Optometrist; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Rob Steller, OD's 2023 MIPS final score plotted against the Vision Therapy Optometrist national average
- MIPS Final Score
- 78.4/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Vision Therapy Optometrist US NPIs
78.4/100 MIPS final score - 5.1 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Vision Therapy Optometrist. Quality dim: 99.1. Cost dim: 28.8.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1982796066 |
|---|---|
| Specialty | Vision Therapy Optometrist |
| Credentials | OD |
| Gender | Male |
| NPI Issued | 09/28/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Rob Steller, OD's current license status, disciplinary history, and board certifications with the Indiana Medical Licensing Board in Indiana before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1982796066 is the unique 10-digit identifier CMS uses to link Steller across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Rob Steller, OD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Rob Steller, OD. Source: openpaymentsdata.cms.gov.
Total received
$149
Largest payer
RxSight Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
34% brand-name claims vs 66% generic, on 247 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 400.5
- Total Day Supply
- 10,962
- Brand vs Generic
- 34% brand / 66% generic
- Brand Drug Cost
- $22K
- Generic Drug Cost
- $6K
Patient Demographics
- Average Patient Age
- 73.1 years
- Avg HCC Risk Score
- 1.19
- Gender Split
- 58% female / 42% male
- Age Distribution
- <65: 13, 65-74: 44, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Rob Steller, OD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Latanoprost
Latanoprost
84 claims
- Tobramycin-Dexamet…
Tobramycin-Dexamethasone
44 claims
- Combigan 17
Combigan
17 claims
- Lumigan 17
Lumigan
17 claims
| Drug | Claims |
|---|---|
| Latanoprost | 84 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 44 |
| Combigan Brimonidine Tartrate/Timolol | 17 |
| Lumigan Bimatoprost | 17 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Vision Therapy Optometrist Overview
How Rob Steller, OD fits within the Vision Therapy Optometrist landscape nationally.
Rob Steller, OD's 247 claims are above the specialty average of 236.
Nationwide Vision Therapy Optometrist peers with similar MIPS or enrollment year
Two federal-record peer sets for Steller, both outside Indiana so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (78.4 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Vision Therapy Optometrist Providers in Indiana
Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as Steller.
One of 9 Vision Therapy Optometrist providers enrolled in Indiana, 5 are shown here.
Compare Vision Therapy Optometrist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Rob Steller, OD's specialty? ▼
How much does Rob Steller, OD prescribe under Medicare Part D? ▼
What is Rob Steller, OD's Medicare quality score? ▼
Where is Rob Steller, OD located? ▼
What is Rob Steller, OD's NPI number? ▼
Does Rob Steller, OD prescribe more brand-name or generic drugs? ▼
How many Vision Therapy Optometrist providers are there in the US? ▼
What drugs does Rob Steller, OD prescribe most often? ▼
Does Rob Steller, OD accept Medicare? ▼
How can I verify Rob Steller, OD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.